Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Patent
1988-03-31
1989-01-03
Yasko, John D.
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
604136, 604187, A61M 520
Patent
active
047954337
ABSTRACT:
A method of treating a patient with liquid medicament under circumstances where intravenous injection is not practical but the fast response time of an intravenous injection is desirable, including the treatment of individuals undergoing heart attack symptoms with t-PA. The method comprises the steps of injecting the liquid medicament t-PA preferably with a blood absorption enhancing agent such as hydroxylamine hydrochloride into the muscle tissue of the patient, applying to the patient which has received the injection repeated blood flow stimulating cycles, each of which includes a period of electrical stimulus during which the muscle tissue which has received the injection tenses followed by a period of no electrical stimulus during which the muscle tissue which received the injection is allowed to relax inducing enhanced blood flow within the muscle tissue, and continuing the application of the repeated blood flow stimulating cycles until the injected liquid medicament has been sufficiently absorbed into the enhanced blood flow to achieve a desired possible patient response of reperfusion and apparatus for carrying out the method.
REFERENCES:
patent: 2771554 (1956-11-01), Gratzl
patent: 3078850 (1963-02-01), Schein
patent: 3364929 (1968-01-01), Ide
patent: 3380449 (1968-04-01), Sarnoff
patent: 3391695 (1968-07-01), Sarnoff
patent: 3424155 (1969-01-01), Sarnoff
patent: 3565080 (1971-02-01), Ide
patent: 3807411 (1974-04-01), Harris
patent: 3882863 (1975-05-01), Sarnoff
patent: 4031893 (1977-06-01), Kaplan
patent: 4103690 (1978-08-01), Harris
patent: 4226235 (1980-10-01), Sarnoff
patent: 4394863 (1983-07-01), Bartner
patent: 4656034 (1987-04-01), Sarnoff
patent: 4658830 (1987-04-01), Sarnoff
patent: 4661469 (1987-04-01), Sarnoff
Iizuka, et al.-Chem. Abst., vol. 77 (1972) p. 17315u.
Korninger et al.-Chem. Abst., vol. 95 (1981) p. 197233u.
Belousov, et al.-Chem. Abst., vol. 92 (1980) p. 39285w.
Lawrence K. Altman, The New York Times, "Protein of Cancer Cells Used to Halt Coronaries", Nov. 16, 1983.
Eugene G. Levin, Proc. Natl. Acad. Sci. USA, "Latent Tissue Plasminogen Activator Produced by Human Endothelial Cells in Culture: Evidence for an Enzyme-Inhibitor Complex", Nov. 1983, vol. 80, pp. 6804-6808.
Frans van de Werf, et al., The New England Journal of Medicine, "Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction", Mar. 8, 1984, vol. 310, No. 10, pp. 609-613.
Keith A. A. Fox, et al., Biochemical Pharmacology, Commentary, "Coronary Thrombolysis: Pharmacological Considerations with Emphasis on Tissue-Type Plasminogen Activator" (t-PA), 1984, vol. 33, No. 12, pp. 1831-1838.
Survival Technology Inc.
Yasko John D.
LandOfFree
Automatic injector for emergency treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Automatic injector for emergency treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Automatic injector for emergency treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2166293